← FDA DRUG APPROVALS

FDA ANDA · ANDA075751

DESONIDE

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA075751
TYPE
ANDA
ORIGINAL APPROVAL
2001-03-12
LATEST ACTION
2016-01-10
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

DESONIDEPrescription
DESONIDE 0.05% · OINTMENT · TOPICAL

Approval history

2016-01-10Labeling · Supplement 6 · standardAP
2001-08-23Manufacturing (CMC) · Supplement 1AP
2001-03-12OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →